Anthion Partners II LLC insider trades: Kalobios Pharmaceuticals (KBIO) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Anthion Partners II LLC reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 16, 2015 | KBIO | ↑ Buy | 3,410 | $29.32 | $100K | Direct | Dec 17, 2015 (1d) |
| Dec 16, 2015 | KBIO | ↑ Buy | 3,410 | $29.32 | $100K | Through Anthion Partners II LLC | Dec 17, 2015 (1d) |
| Nov 18, 2015 | KBIO | ↑ Buy | 150,000 | $2.13 | $320K | Through Anthion Partners II LLC | Nov 19, 2015 (1d) |
| Nov 18, 2015 | KBIO | ↑ Buy | 150,000 | $2.13 | $320K | Direct | Nov 19, 2015 (1d) |
| Nov 17, 2015 | KBIO | ↑ Buy | 356,863 | $1.42 | $507K | Through Anthion Partners II LLC | Nov 18, 2015 (1d) |
| Nov 17, 2015 | KBIO | ↑ Buy | 356,863 | $1.42 | $507K | Direct | Nov 18, 2015 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Anthion Partners II LLC's insider trades
Anthion Partners II LLC is a 10% owner of Kalobios Pharmaceuticals (KBIO). Since Nov 17, 2015, it has reported 6 open-market purchases worth $1.9M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KBIO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.